[Efficacy of biventricular pacing on myocardial glucose metabolism in a patient with heart failure using 2-deoxy-2[18F]fluoro-d-glucose positron emission tomography: a case report].
A 61-year-old-male with dilated cardiomyopathy and congestive heart failure was treated by implantation of a biventricular pacemaker. Myocardial glucose metabolism was evaluated by positron emission tomography with 2-deoxy-2[18F]fluoro-d-glucose (FDG) during atrial-right ventricular pacing or atrial-biventricular pacing. Percentage uptake of FDG decreased in the lower septal area of the left ventricle during right ventricular pacing, but the decrease was improved during biventricular pacing (74.7% vs 91.6%). Biventricular pacing may improve myocardial glucose metabolism in patients with congestive heart failure.
Okusu
Yasuo
Y
Second Department of Internal Medicine, Yokohama City University School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama 236-0004.
Ishikawa
Toshiyuki
T
Takahashi
Nobukazu
N
Oka
Takashi
T
Sumita
Shinichi
S
Kobayashi
Tsukasa
T
Matsushita
Kohei
K
Yamakawa
Youhei
Y
Uchino
Kazuaki
K
Matsubara
Sho
S
Kimura
Kazuo
K
Inoue
Tomio
T
Umemura
Satoshi
S
D002304:Cardiac Pacing, Artificial; D002311:Cardiomyopathy, Dilated / Q000150:complications; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006333:Heart Failure / Q000000981:diagnostic imaging* / Q000378:metabolism* / Q000628:therapy; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005947:Glucose